Azitra CEO receives stock options for 59,309 shares at $0.2968

Azitra, Inc. reported an equity award to its President, CEO and director, Francisco D. Salva.

Rhea-AI Filing Summary

Azitra, Inc. reported an equity award to its President, CEO and director, Francisco D. Salva. On 12/19/2025, he received a stock option to buy 59,309 shares of Azitra common stock at an exercise price of $0.2968 per share. The option expires on 12/19/2035.

According to the vesting terms, 25% of the shares vest on the grant date, with the remaining shares vesting in equal monthly installments over the next 36 months of continuous service. Following this grant, 59,309 derivative securities are beneficially owned directly.

Insider Trade Summary

Grant/Award: 59,309 shares

Grant/Award 1 txn

Insider Salva Francisco D.

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right To Buy)	59,309	$0.00	$0.00

Holdings After Transaction: Stock Options (Right To Buy) — 59,309 contracts (Direct)

Footnotes (1)

1. F1. 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Azitra (AZTR) report in this Form 4?

Azitra reported that its President, CEO and director, Francisco D. Salva, received a stock option grant for 59,309 shares of common stock on 12/19/2025.

What is the exercise price and term of the new Azitra (AZTR) stock options?

The stock options have an exercise price of $0.2968 per share and expire on 12/19/2035.

How do the Azitra (AZTR) CEO’s new stock options vest?

The filing states that 25% of the option shares vest on the grant date, the vesting commencement date, and the remaining balance vests in equal monthly installments over the next 36 months of continuous service.

How many derivative securities does the Azitra (AZTR) CEO own after this transaction?

Following the reported transaction, the Form 4 shows that 59,309 derivative securities (stock options) are beneficially owned directly by Francisco D. Salva.

What role does the reporting person hold at Azitra (AZTR)?

The reporting person, Francisco D. Salva, is identified as a Director and an Officer, serving as President and CEO of Azitra, Inc.

Was this Azitra (AZTR) Form 4 filed for one or multiple reporting persons?

The document indicates that the Form 4 was filed by one reporting person, Francisco D. Salva.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/22/2025 - 05:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Salva Francisco D.

(Last) (First) (Middle)

21 BUSINESS PARK DRIVE

(Street)

BRANFORD CT 06405

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Azitra, Inc. [ AZTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right To Buy)	$0.2968	12/19/2025		A		59,309		(1)	12/19/2035	Common Stock	59,309	$0.00	59,309	D

Explanation of Responses:

1. 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter.

	/s/ Francisco D. Salva	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.